MetrioPharm
Pre-clinicalDevelops small molecule therapeutics targeting inflammatory and fibrotic diseases through modulation of macrophage function.
Founded
2008
Focus
Small Molecules
About
Develops small molecule therapeutics targeting inflammatory and fibrotic diseases through modulation of macrophage function.
Funding History
2Total raised: $12.4M
Grant$2.4MEuropean UnionJun 15, 2020
Series A$10MUndisclosedJun 15, 2018
Company Info
TypePrivate
Founded2008
LocationZürich, Switzerland
StagePre-clinical
Contact
SIMILAR COMPANIES
3Brain
Pre-clinical · Zug
Baxiva
Pre-clinical · Zug
AC Bioscience
Pre-clinical · Lausanne
Abrinca Genomics
Pre-clinical · Zurich
AdipoGen
Pre-clinical · Liestal
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile